SHL Telemedicine

Company Overview

Snapshot

Founded in January 1987 by Yariv Alroy, SHL Telemedicine operates with 51–200 employees. The company has raised a total of $109 million across three funding rounds from three investors. In March 2023, SHL Telemedicine commenced trading on NASDAQ.

Business overview

SHL Telemedicine develops ECG and supporting devices, platforms, and software for home care, aiming to enhance survival rates during cardiac events and improve post-medical emergency quality of life. The company's offerings include intuitive, compact, and sophisticated ECG devices capable of recording 12 hospital-grade ECGs within seconds. At the core of its service is a 24/7 telemedicine center staffed by a professional medical team, providing evaluation and care. SHL Telemedicine serves markets in Europe, the United States, Germany, China, and India, operating within the Digital Health and Medical Technologies sector, focusing on patient remote monitoring, medical devices, and diagnostics.

Strategic signal

In May 2024, SHL Telemedicine expanded its offerings in Israel by introducing a groundbreaking at-home biomarker blood test. This move signifies the company's strategic intent to broaden its diagnostic capabilities beyond traditional ECG monitoring and enhance its direct-to-consumer strategy, providing a more comprehensive home-based health monitoring solution to its users.

Company Intelligence Q&A

When did SHL Telemedicine go public on NASDAQ?

SHL Telemedicine commenced trading on NASDAQ in March 2023 under the ticker SHLT.

What significant product expansion did SHL Telemedicine announce in Israel?

In May 2024, SHL Telemedicine expanded its offerings in Israel with the introduction of an at-home biomarker blood test.

What was a key strategic move for SHL Telemedicine in the US in November 2023?

In November 2023, SHL Telemedicine established a US nationwide cardiology network for ECG interpretations and telehealth visits.

What was the outcome of SHL Telemedicine's SmartHeart® technology trials in September 2023?

In September 2023, SHL Telemedicine's SmartHeart® technology demonstrated remarkable effects in trials conducted by Mayo Clinic and Imperial College London.

Which company did SHL Telemedicine acquire in August 2021?

In August 2021, SHL Telemedicine acquired a majority stake in Mediton Group, a B2B healthcare services provider in Israel.